He was notably Chairman of the Glaxo Group. As of 2014 the title has been held by his grandson, the fourth Baronet, who succeeded his father in 2012.
He served as a notable chairman of the Glaxo Group. By 2014, the role was occupied by his grandson, the fourth Baronet, who took over from his father in 2012.